Healthcare analytics company (and one of our top 5 digital health startups to watch) Komodo Health recently scored $220 million in a Series E funding round that brought its valuation to $3.3 billion. For context, Komodo Health offers healthcare stakeholders a suite of solutions based on its proprietary AI-powered analytics tool, Healthcare Map, which tracks over 320 million deidentified patient encounters to glean real-world insights.
We spoke to Komodo Health’s CEO, Arif Nathoo, to learn more about the massive funding haul and where Komodo is headed—here’s what he told us:
This funding haul builds on a busy year for Komodo Health:
Real-world data is the foundation to build a more effective and efficient value-based healthcare system—and companies like Komodo Health will drive this shift. The pandemic turbocharged digital health transformation in the US: In 2020, healthcare data analytics was a top-funded digital health category, securing a whopping $1.8 billion, per Mercom Capital. But challenges around interoperability and disjointed communication between providers, payers, and other healthcare stakeholders inhibit better patient outcomes. Healthcare analytics solutions that leverage real-world patient data can help make healthcare less fragmented, synergize a patient’s healthcare journey, and effectively boost healthcare outcomes across the board: For example, AI-enabled analytics of representative population datasets can help providers make tailored clinical decisions, and drive precision medicine efforts that improve patient outcomes.